{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:00:50Z","timestamp":1792000850327,"version":"4.4.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10096-015-2501-z","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T07:50:01Z","timestamp":1444117801000},"page":"2313-2324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clostridium difficile infection in patients with liver disease: a review"],"prefix":"10.1007","volume":"34","author":[{"given":"A.","family":"Trifan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Stoica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Stanciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cojocariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Singeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Girleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Miftode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"2501_CR1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/egh.10.48","volume":"4","author":"S Khanna","year":"2010","unstructured":"Khanna S, Pardi DS (2010) The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 4:409\u2013416. doi: 10.1586\/egh.10.48","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2501_CR2","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1093\/jac\/dkt257","volume":"68","author":"CA Marwick","year":"2013","unstructured":"Marwick CA, Yu N, Lockhart MC, McGuigan CC, Wiuff C, Davey PG, Donnan PT (2013) Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case\u2013control. J Antimicrob Chemother 68:2927\u20132933. doi: 10.1093\/jac\/dkt257","journal-title":"J Antimicrob Chemother"},{"key":"2501_CR3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","volume":"365","author":"VG Loo","year":"2011","unstructured":"Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, B\u00e9liveau C, Oughton M, Brukner I, Dascal A (2011) Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 365:1693\u20131703. doi: 10.1056\/NEJMoa1012413","journal-title":"N Engl J Med"},{"key":"2501_CR4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","volume":"107","author":"CS Kwok","year":"2012","unstructured":"Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK (2012) Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 107:1011\u20131019. doi: 10.1038\/ajg.2012.108","journal-title":"Am J Gastroenterol"},{"key":"2501_CR5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"LC McDonald","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353:2433\u20132441","journal-title":"N Engl J Med"},{"key":"2501_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ajg.2009.615","volume":"105","author":"JS Bajaj","year":"2010","unstructured":"Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, Saeian K, Heuman D, Sanyal AJ, Hoffmann RG (2010) Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. Am J Gastroenterol 105:106\u2013113. doi: 10.1038\/ajg.2009.615","journal-title":"Am J Gastroenterol"},{"key":"2501_CR7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/lt.23449","volume":"18","author":"M Ali","year":"2012","unstructured":"Ali M, Ananthakrishnan AN, Ahmad S, Kumar N, Kumar G, Saeian K (2012) Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl 18:972\u2013978. doi: 10.1002\/lt.23449","journal-title":"Liver Transpl"},{"key":"2501_CR8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/ajt.12798","volume":"14","author":"C Mittal","year":"2014","unstructured":"Mittal C, Hassan S, Arshad S, Jeepalyam S, Bruni S, Miceli M, Jacobsen G, Abouljoud M, Bajjoka I, Ramesh M, Alangaden G (2014) Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes. Am J Transplant 14:1901\u20131907. doi: 10.1111\/ajt.12798","journal-title":"Am J Transplant"},{"key":"2501_CR9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Gin\u00e8s P, Arroyo V (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818\u2013824","journal-title":"Gastroenterology"},{"key":"2501_CR10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MEG.0b013e3282f4aa01","volume":"20","author":"E Kalaitzakis","year":"2008","unstructured":"Kalaitzakis E, Bj\u00f6rnsson E (2008) Inadequate use of proton-pump inhibitors in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 20:512\u2013518. doi: 10.1097\/MEG.0b013e3282f4aa01","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2501_CR11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","volume":"9","author":"AR Bonnel","year":"2011","unstructured":"Bonnel AR, Bunchorntavakul C, Reddy KR (2011) Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol 9:727\u2013738. doi: 10.1016\/j.cgh.2011.02.031","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2501_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/apt.12797","volume":"40","author":"AK Singal","year":"2014","unstructured":"Singal AK, Salameh H, Kamath PS (2014) Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States. Aliment Pharmacol Ther 40:105\u2013112. doi: 10.1111\/apt.12797","journal-title":"Aliment Pharmacol Ther"},{"key":"2501_CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/511790","volume":"28","author":"D Vanjak","year":"2007","unstructured":"Vanjak D, Girault G, Branger C, Rufat P, Valla DC, Fantin B (2007) Risk factors for Clostridium difficile infection in a hepatology ward. Infect Control Hosp Epidemiol 28:202\u2013204","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2501_CR14","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cgh.2014.02.041","volume":"12","author":"V Sundaram","year":"2014","unstructured":"Sundaram V, May FP, Manne V, Saab S (2014) Effects of Clostridium difficile infection in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 12:1745\u20131752. doi: 10.1016\/j.cgh.2014.02.041","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2501_CR15","first-page":"303","volume":"19","author":"S Musa","year":"2010","unstructured":"Musa S, Moran C, Rahman T (2010) Clostridium difficile infection and liver disease. J Gastrointestin Liver Dis 19:303\u2013310","journal-title":"J Gastrointestin Liver Dis"},{"key":"2501_CR16","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","volume":"56","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, O\u2019Leary JG, Reddy KR, Wong F, Olson JC, Subramanian RM, Brown G, Noble NA, Thacker LR, Kamath PS; NACSELD (2012) Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 56:2328\u20132335. doi: 10.1002\/hep.25947","journal-title":"Hepatology"},{"key":"2501_CR17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2036.2011.04984.x","volume":"35","author":"S Khanna","year":"2012","unstructured":"Khanna S, Pardi DS, Aronson SL, Kammer PP, Baddour LM (2012) Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol Ther 35:613\u2013618. doi: 10.1111\/j.1365-2036.2011.04984.x","journal-title":"Aliment Pharmacol Ther"},{"key":"2501_CR18","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","volume":"294","author":"S Dial","year":"2005","unstructured":"Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294:2989\u20132995","journal-title":"JAMA"},{"issue":"Suppl 1","key":"2501_CR19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","volume":"56","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez J, Gustot T (2012) Management of bacterial infections in cirrhosis. J Hepatol 56(Suppl 1):S1\u2013S12. doi: 10.1016\/S0168-8278(12)60002-6","journal-title":"J Hepatol"},{"key":"2501_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1590-8658(01)80134-1","volume":"33","author":"M Borzio","year":"2001","unstructured":"Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistar\u00e0 R, Salvagnini M, Sangiovanni A (2001) Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33:41\u201348","journal-title":"Dig Liver Dis"},{"key":"2501_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","volume":"28","author":"P Tandon","year":"2008","unstructured":"Tandon P, Garcia-Tsao G (2008) Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 28:26\u201342. doi: 10.1055\/s-2008-1040319","journal-title":"Semin Liver Dis"},{"key":"2501_CR22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cgh.2010.06.024","volume":"8","author":"M Merli","year":"2010","unstructured":"Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M (2010) Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 8:979\u2013985. doi: 10.1016\/j.cgh.2010.06.024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2501_CR23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez J, Navasa M, G\u00f3mez J, Colmenero J, Vila J, Arroyo V, Rod\u00e9s J (2002) Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35:140\u2013148","journal-title":"Hepatology"},{"key":"2501_CR24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, Seva-Pereira T, Corradi F, Mensa J, Gin\u00e8s P, Arroyo V (2012) Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 55:1551\u20131561. doi: 10.1002\/hep.25532","journal-title":"Hepatology"},{"key":"2501_CR25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1086\/596703","volume":"48","author":"D Gravel","year":"2009","unstructured":"Gravel D, Miller M, Simor A, Taylor G, Gardam M, McGeer A, Hutchinson J, Moore D, Kelly S, Boyd D, Mulvey M; Canadian Nosocomial Infection Surveillance Program (2009) Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 48:568\u2013576. doi: 10.1086\/596703","journal-title":"Clin Infect Dis"},{"key":"2501_CR26","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3748\/wjg.v13.i14.2072","volume":"13","author":"M Hashimoto","year":"2007","unstructured":"Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuch M (2007) Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol 13:2072\u20132076","journal-title":"World J Gastroenterol"},{"key":"2501_CR27","first-page":"70","volume":"10","author":"M Niemczyk","year":"2005","unstructured":"Niemczyk M, Leszczy\u0144iski P, Wyzga\u0142 J, Paczek L, Krawczyk M, Luczak M (2005) Infections caused by Clostridium difficile in kidney or liver graft recipients. Ann Transplant 10:70\u201374","journal-title":"Ann Transplant"},{"key":"2501_CR28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1432-2277.2007.00530.x","volume":"20","author":"JB Albright","year":"2007","unstructured":"Albright JB, Bonatti H, Mendez J, Kramer D, Stauffer J, Hinder R, Michel JA, Dickson RC, Hughes C, Nguyen J, Chua H, Hellinger W (2007) Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 20:856\u2013866","journal-title":"Transpl Int"},{"key":"2501_CR29","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10620-007-9770-z","volume":"52","author":"I Stelzmueller","year":"2007","unstructured":"Stelzmueller I, Goegele H, Biebl M, Wiesmayr S, Berger N, Tabarelli W, Ruttmann E, Albright J, Margreiter R, Fille M, Bonatti H (2007) Clostridium difficile colitis in solid organ transplantation\u2014a single-center experience. Dig Dis Sci 52:3231\u20133236","journal-title":"Dig Dis Sci"},{"key":"2501_CR30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1198-743x.2001.00289.x","volume":"7","author":"F Barbut","year":"2001","unstructured":"Barbut F, Petit JC (2001) Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7:405\u2013410","journal-title":"Clin Microbiol Infect"},{"key":"2501_CR31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1017\/S0950268806007655","volume":"135","author":"DB Scheurer","year":"2007","unstructured":"Scheurer DB, Hicks LS, Cook EF, Schnipper JL (2007) Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect 135:1010\u20131013","journal-title":"Epidemiol Infect"},{"key":"2501_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2011.05.010","volume":"79","author":"MH Wilcox","year":"2011","unstructured":"Wilcox MH (2011) Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both? J Hosp Infect 79:1\u20133. doi: 10.1016\/j.jhin.2011.05.010","journal-title":"J Hosp Infect"},{"key":"2501_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","volume":"377","author":"MP Bauer","year":"2011","unstructured":"Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ; ECDIS Study Group (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63\u201373. doi: 10.1016\/S0140-6736(10)61266-4","journal-title":"Lancet"},{"key":"2501_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1469-0691.12057","volume":"18","author":"MH Wilcox","year":"2012","unstructured":"Wilcox MH (2012) Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 18:13\u201320. doi: 10.1111\/1469-0691.12057","journal-title":"Clin Microbiol Infect"},{"key":"2501_CR35","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"VG Loo","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Ren\u00e9 P, Monczak Y, Dascal A (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442\u20132449","journal-title":"N Engl J Med"},{"key":"2501_CR36","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J P\u00e9pin","year":"2005","unstructured":"P\u00e9pin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41:1254\u20131260","journal-title":"Clin Infect Dis"},{"key":"2501_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola A, Garc\u00eda-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32:142\u2013153","journal-title":"J Hepatol"},{"key":"2501_CR38","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2009.191","volume":"104","author":"G Garcia-Tsao","year":"2009","unstructured":"Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program (2009) Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 104:1802\u20131829. doi: 10.1038\/ajg.2009.191","journal-title":"Am J Gastroenterol"},{"key":"2501_CR39","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.3748\/wjg.v16.i42.5317","volume":"16","author":"MR Brown","year":"2010","unstructured":"Brown MR, Jones G, Nash KL, Wright M, Guha IN (2010) Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates. World J Gastroenterol 16:5317\u20135323","journal-title":"World J Gastroenterol"},{"key":"2501_CR40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MCG.0b013e318276be13","volume":"47","author":"GW Neff","year":"2013","unstructured":"Neff GW, Jones M, Jonas M, Ravinuthala R, Novick D, Kaiser TE, Kemmer N (2013) Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis. J Clin Gastroenterol 47:188\u2013192. doi: 10.1097\/MCG.0b013e318276be13","journal-title":"J Clin Gastroenterol"},{"key":"2501_CR41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/lt.22092","volume":"16","author":"G Neff","year":"2010","unstructured":"Neff G, Zacharias V, Kaiser TE, Gaddis A, Kemmer N (2010) Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series. Liver Transpl 16:960\u2013963. doi: 10.1002\/lt.22092","journal-title":"Liver Transpl"},{"key":"2501_CR42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2004.09.001","volume":"41","author":"G Garcia-Tsao","year":"2004","unstructured":"Garcia-Tsao G (2004) Spontaneous bacterial peritonitis: a historical perspective. J Hepatol 41:522\u2013527","journal-title":"J Hepatol"},{"key":"2501_CR43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1399-3062.2007.00255.x","volume":"9","author":"ZF Gellad","year":"2007","unstructured":"Gellad ZF, Alexander BD, Liu JK, Griffith BC, Meyer AM, Johnson JL, Muir AJ (2007) Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis 9:276\u2013280","journal-title":"Transpl Infect Dis"},{"key":"2501_CR44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-0012.1999.130407.x","volume":"13","author":"M West","year":"1999","unstructured":"West M, Pirenne J, Chavers B, Gillingham K, Sutherland DE, Dunn DL, Matas AJ (1999) Clostridium difficile colitis after kidney and kidney\u2013pancreas transplantation. Clin Transplant 13:318\u2013323","journal-title":"Clin Transplant"},{"key":"2501_CR45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/lt.22291","volume":"17","author":"RR Razonable","year":"2011","unstructured":"Razonable RR, Findlay JY, O\u2019Riordan A, Burroughs SG, Ghobrial RM, Agarwal B, Davenport A, Gropper M (2011) Critical care issues in patients after liver transplantation. Liver Transpl 17:511\u2013527. doi: 10.1002\/lt.22291","journal-title":"Liver Transpl"},{"key":"2501_CR46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1503\/cmaj.060284","volume":"175","author":"S Dial","year":"2006","unstructured":"Dial S, Delaney JA, Schneider V, Suissa S (2006) Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 175:745\u2013748","journal-title":"CMAJ"},{"key":"2501_CR47","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J Leonard","year":"2007","unstructured":"Leonard J, Marshall JK, Moayyedi P (2007) Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102:2047\u20132056","journal-title":"Am J Gastroenterol"},{"key":"2501_CR48","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","volume":"107","author":"S Janarthanan","year":"2012","unstructured":"Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN (2012) Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 107:1001\u20131010. doi: 10.1038\/ajg.2012.179","journal-title":"Am J Gastroenterol"},{"key":"2501_CR49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1086\/508453","volume":"43","author":"DO Lowe","year":"2006","unstructured":"Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN (2006) Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis 43:1272\u20131276","journal-title":"Clin Infect Dis"},{"key":"2501_CR50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2007.05.031","volume":"133","author":"CM Surawicz","year":"2007","unstructured":"Surawicz CM (2007) The acid test: is proton pump inhibitor therapy an independent risk factor for Clostridium difficile-associated disease? Gastroenterology 133:355\u2013357","journal-title":"Gastroenterology"},{"key":"2501_CR51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apt.13061","volume":"41","author":"G Dultz","year":"2015","unstructured":"Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O (2015) Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Aliment Pharmacol Ther 41:459\u2013466. doi: 10.1111\/apt.13061","journal-title":"Aliment Pharmacol Ther"},{"key":"2501_CR52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.20593","volume":"41","author":"NJ Shaheen","year":"2005","unstructured":"Shaheen NJ, Stuart E, Schmitz SM, Mitchell KL, Fried MW, Zacks S, Russo MW, Galanko J, Shrestha R (2005) Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology 41:588\u2013594","journal-title":"Hepatology"},{"key":"2501_CR53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1592\/phco.29.3.248","volume":"29","author":"C Alaniz","year":"2009","unstructured":"Alaniz C, Mohammad RA, Welage LS (2009) Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhage. Pharmacotherapy 29:248\u2013254. doi: 10.1592\/phco.29.3.248","journal-title":"Pharmacotherapy"},{"key":"2501_CR54","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/AAC.01443-06","volume":"51","author":"RL Jump","year":"2007","unstructured":"Jump RL, Pultz MJ, Donskey CJ (2007) Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 51:2883\u20132887","journal-title":"Antimicrob Agents Chemother"},{"key":"2501_CR55","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/j.1572-0241.2002.05791.x","volume":"97","author":"TM Bauer","year":"2002","unstructured":"Bauer TM, Schwacha H, Steinbr\u00fcckner B, Brinkmann FE, Ditzen AK, Aponte JJ, Pelz K, Berger D, Kist M, Blum HE (2002) Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 97:2364\u20132370","journal-title":"Am J Gastroenterol"},{"key":"2501_CR56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.42.2.243","volume":"42","author":"HP Parkman","year":"1998","unstructured":"Parkman HP, Urbain JL, Knight LC, Brown KL, Trate DM, Miller MA, Maurer AH, Fisher RS (1998) Effect of gastric acid suppressants on human gastric motility. Gut 42:243\u2013250","journal-title":"Gut"},{"key":"2501_CR57","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-200205000-00026","volume":"30","author":"K Zedtwitz-Liebenstein","year":"2002","unstructured":"Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxb\u00f6ck F, Graninger W (2002) Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30:1118\u20131122","journal-title":"Crit Care Med"},{"key":"2501_CR58","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3748\/wjg.14.2980","volume":"14","author":"F Lodato","year":"2008","unstructured":"Lodato F, Azzaroli F, Di Girolamo M, Feletti V, Cecinato P, Lisotti A, Festi D, Roda E, Mazzella G (2008) Proton pump inhibitors in cirrhosis: tradition or evidence based practice? World J Gastroenterol 14:2980\u20132985","journal-title":"World J Gastroenterol"},{"key":"2501_CR59","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ajg.2009.80","volume":"104","author":"JS Bajaj","year":"2009","unstructured":"Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K (2009) Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 104:1130\u20131134. doi: 10.1038\/ajg.2009.80","journal-title":"Am J Gastroenterol"},{"key":"2501_CR60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1742-1241.2011.02650.x","volume":"65","author":"G Trikudanathan","year":"2011","unstructured":"Trikudanathan G, Israel J, Cappa J, O\u2019Sullivan DM (2011) Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients\u2014a systematic review and meta-analysis. Int J Clin Pract 65:674\u2013678. doi: 10.1111\/j.1742-1241.2011.02650.x","journal-title":"Int J Clin Pract"},{"key":"2501_CR61","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/apt.12072","volume":"36","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Ratliff SM, Heuman DM, Lapane KL (2012) Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther 36:866\u2013874","journal-title":"Aliment Pharmacol Ther"},{"key":"2501_CR62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cgh.2011.11.019","volume":"10","author":"GA Goel","year":"2012","unstructured":"Goel GA, Deshpande A, Lopez R, Hall GS, van Duin D, Carey WD (2012) Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol 10:422\u2013427. doi: 10.1016\/j.cgh.2011.11.019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2501_CR63","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/liv.12210","volume":"33","author":"M Vos de","year":"2013","unstructured":"de Vos M, De Vroey B, Garcia BG, Roy C, Kidd F, Henrion J, Deltenre P (2013) Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Liver Int 33:1316\u20131323. doi: 10.1111\/liv.12210","journal-title":"Liver Int"},{"key":"2501_CR64","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jgh.12426","volume":"29","author":"JH Kwon","year":"2014","unstructured":"Kwon JH, Koh SJ, Kim W, Jung YJ, Kim JW, Kim BG, Lee KL, Im JP, Kim YJ, Kim JS, Yoon JH, Lee HS, Jung HC (2014) Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis. J Gastroenterol Hepatol 29:775\u2013781. doi: 10.1111\/jgh.12426","journal-title":"J Gastroenterol Hepatol"},{"key":"2501_CR65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jgh.12065","volume":"28","author":"A Deshpande","year":"2013","unstructured":"Deshpande A, Pasupuleti V, Thota P, Pant C, Mapara S, Hassan S, Rolston DD, Sferra TJ, Hernandez AV (2013) Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. J Gastroenterol Hepatol 28:235\u2013242. doi: 10.1111\/jgh.12065","journal-title":"J Gastroenterol Hepatol"},{"key":"2501_CR66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/658669","volume":"32","author":"MK Shaughnessy","year":"2011","unstructured":"Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, Chenoweth CE (2011) Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 32:201\u2013206. doi: 10.1086\/658669","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2501_CR67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","volume":"7","author":"M Rupnik","year":"2009","unstructured":"Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526\u2013536. doi: 10.1038\/nrmicro2164","journal-title":"Nat Rev Microbiol"},{"key":"2501_CR68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1099\/jmm.0.45804-0","volume":"54","author":"F Barbut","year":"2005","unstructured":"Barbut F, Decr\u00e9 D, Lalande V, Burghoffer B, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, Branger C, Petit JC (2005) Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54:181\u2013185","journal-title":"J Med Microbiol"},{"key":"2501_CR69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1443-9573.2004.00157.x","volume":"5","author":"HY Zhao","year":"2004","unstructured":"Zhao HY, Wang HJ, Lu Z, Xu SZ (2004) Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis 5:64\u201367","journal-title":"Chin J Dig Dis"},{"key":"2501_CR70","first-page":"869","volume":"114","author":"L Li","year":"2001","unstructured":"Li L, Wu Z, Ma W, Yu Y, Chen Y (2001) Changes in intestinal microflora in patients with chronic severe hepatitis. Chin Med J (Engl) 114:869\u2013872","journal-title":"Chin Med J (Engl)"},{"key":"2501_CR71","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","volume":"42","author":"IA Kirpich","year":"2008","unstructured":"Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M (2008) Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42:675\u2013682. doi: 10.1016\/j.alcohol.2008.08.006","journal-title":"Alcohol"},{"key":"2501_CR72","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/gut.2004.038679","volume":"54","author":"F Wong","year":"2005","unstructured":"Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M; International Ascites Club (2005) Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54:718\u2013725","journal-title":"Gut"},{"key":"2501_CR73","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1093\/cid\/cit392","volume":"57","author":"E Mattila","year":"2013","unstructured":"Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila VJ (2013) Extraintestinal Clostridium difficile infections. Clin Infect Dis 57:e148\u2013e153. doi: 10.1093\/cid\/cit392","journal-title":"Clin Infect Dis"},{"key":"2501_CR74","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:478\u2013498. doi: 10.1038\/ajg.2013.4","journal-title":"Am J Gastroenterol"},{"key":"2501_CR75","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/cid\/cir201","volume":"52","author":"AM Kufelnicka","year":"2011","unstructured":"Kufelnicka AM, Kirn TJ (2011) Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection. Clin Infect Dis 52:1451\u20131457. doi: 10.1093\/cid\/cir201","journal-title":"Clin Infect Dis"},{"key":"2501_CR76","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1473-3099(08)70233-0","volume":"8","author":"T Planche","year":"2008","unstructured":"Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, Krishna S (2008) Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 8:777\u2013784. doi: 10.1016\/S1473-3099(08)70233-0","journal-title":"Lancet Infect Dis"},{"key":"2501_CR77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.anaerobe.2011.01.002","volume":"17","author":"KC Carroll","year":"2011","unstructured":"Carroll KC (2011) Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe 17:170\u2013174. doi: 10.1016\/j.anaerobe.2011.01.002","journal-title":"Anaerobe"},{"key":"2501_CR78","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/1469-0691.12221","volume":"20","author":"F Barbut","year":"2014","unstructured":"Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, Grandsire E, Lalande V (2014) Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management? Clin Microbiol Infect 20:136\u2013144. doi: 10.1111\/1469-0691.12221","journal-title":"Clin Microbiol Infect"},{"key":"2501_CR79","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1473-3099(13)70200-7","volume":"13","author":"TD Planche","year":"2013","unstructured":"Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, O\u2019Connor L, Oakley SJ, Pope CF, Wren MW, Shetty NP, Crook DW, Wilcox MH (2013) Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 13:936\u2013945. doi: 10.1016\/S1473-3099(13)70200-7","journal-title":"Lancet Infect Dis"},{"key":"2501_CR80","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cgh.2013.03.016","volume":"11","author":"HL Dupont","year":"2013","unstructured":"Dupont HL (2013) Diagnosis and management of Clostridium difficile infection. Clin Gastroenterol Hepatol 11:1216\u20131223. doi: 10.1016\/j.cgh.2013.03.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2501_CR81","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.med.49.1.375","volume":"49","author":"CP Kelly","year":"1998","unstructured":"Kelly CP, LaMont JT (1998) Clostridium difficile infection. Ann Rev Med 49:375\u2013390","journal-title":"Ann Rev Med"},{"key":"2501_CR82","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2214\/ajr.172.4.10587121","volume":"172","author":"JA Guingrich","year":"1999","unstructured":"Guingrich JA, Kuhlman JE (1999) Colonic wall thickening in patients with cirrhosis: CT findings and clinical implications. AJR Am J Roentgenol 172:919\u2013924","journal-title":"AJR Am J Roentgenol"},{"key":"2501_CR83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","volume":"171","author":"SM Poutanen","year":"2004","unstructured":"Poutanen SM, Simor AE (2004) Clostridium difficile-associated diarrhea in adults. CMAJ 171:51\u201358","journal-title":"CMAJ"},{"key":"2501_CR84","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/605322","volume":"30","author":"MT Oughton","year":"2009","unstructured":"Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD (2009) Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 30:939\u2013944. doi: 10.1086\/605322","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 5","key":"2501_CR85","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2008.01992.x","volume":"14","author":"RP Vonberg","year":"2008","unstructured":"Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, T\u00fcll P, Gastmeier P; European C difficile-Infection Control Group; European Centre for Disease Prevention and Control (ECDC), van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O\u2019Driscoll J, Patel B, Stone S, Wiuff C (2008) Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 14(Suppl 5):2\u201320. doi: 10.1111\/j.1469-0691.2008.01992.x","journal-title":"Clin Microbiol Infect"},{"key":"2501_CR86","first-page":"CD004610","volume":"9","author":"RL Nelson","year":"2011","unstructured":"Nelson RL, Kelsey P, Leeman H, Meardon N, Patel H, Paul K, Rees R, Taylor B, Wood E, Malakun R (2011) Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 9:CD004610. doi: 10.1002\/14651858.CD004610.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2501_CR87","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"FA Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KMLST, Davis MB (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45:302\u2013307","journal-title":"Clin Infect Dis"},{"key":"2501_CR88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/003655401750064112","volume":"33","author":"T Sakurai","year":"2001","unstructured":"Sakurai T, Hajiro K, Takakuwa H, Nishi A, Aihara M, Chiba T (2001) Liver abscess caused by Clostridium difficile. Scand J Infect Dis 33:69\u201370","journal-title":"Scand J Infect Dis"},{"key":"2501_CR89","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK; OPT-80-003 Clinical Study Group (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422\u2013431. doi: 10.1056\/NEJMoa0910812","journal-title":"N Engl J Med"},{"key":"2501_CR90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","volume":"12","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, Sears P, Gorbach S; OPT-80-004 Clinical Study Group (2012) Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis 12:281\u2013289. doi: 10.1016\/S1473-3099(11)70374-7","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"2501_CR91","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/cid\/cis499","volume":"55","author":"DW Crook","year":"2012","unstructured":"Crook DW, Walker AS, Kean Y, Weiss K, Cornely OA, Miller MA, Esposito R, Louie TJ, Stoesser NE, Young BC, Angus BJ, Gorbach SL, Peto TE; Study 003\/004 Teams (2012) Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis 55(Suppl 2):S93\u2013S103. doi: 10.1093\/cid\/cis499","journal-title":"Clin Infect Dis"},{"key":"2501_CR92","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1093\/jac\/dks302","volume":"67","author":"AP Johnson","year":"2012","unstructured":"Johnson AP, Wilcox MH (2012) Fidaxomicin: a new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother 67:2788\u20132792. doi: 10.1093\/jac\/dks302","journal-title":"J Antimicrob Chemother"},{"key":"2501_CR93","doi-asserted-by":"crossref","first-page":"e786","DOI":"10.1016\/j.ijid.2012.06.005","volume":"16","author":"S Johnson","year":"2012","unstructured":"Johnson S, Maziade PJ, McFarland LV, Trick W, Donskey C, Currie B, Low DE, Goldstein EJ (2012) Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis 16:e786\u2013e792. doi: 10.1016\/j.ijid.2012.06.005","journal-title":"Int J Infect Dis"},{"key":"2501_CR94","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-6143.2004.00649.x","volume":"5","author":"N Rayes","year":"2005","unstructured":"Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation\u2014a randomized, double-blind trial. Am J Transplant 5:125\u2013130","journal-title":"Am J Transplant"},{"key":"2501_CR95","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","volume":"9","author":"JS Bakken","year":"2011","unstructured":"Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C; Fecal Microbiota Transplantation Workgroup (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9:1044\u20131049. doi: 10.1016\/j.cgh.2011.08.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2501_CR96","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/cid\/cir632","volume":"53","author":"E Gough","year":"2011","unstructured":"Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53:994\u20131002. doi: 10.1093\/cid\/cir632","journal-title":"Clin Infect Dis"},{"key":"2501_CR97","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCG.0000000000000046","volume":"48","author":"G Cammarota","year":"2014","unstructured":"Cammarota G, Ianiro G, Gasbarrini A (2014) Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48:693\u2013702. doi: 10.1097\/MCG.0000000000000046","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 2","key":"2501_CR98","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/cis356","volume":"55","author":"DW Eyre","year":"2012","unstructured":"Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, O\u2019Connor L, Vaughan A, Crook DW, Wilcox MH, Peto TE; Infections in Oxfordshire Research Database (2012) Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 55(Suppl 2):S77\u2013S87. doi: 10.1093\/cid\/cis356","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"2501_CR99","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","volume":"55","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL (2012) Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis 55(Suppl 2):S154\u2013S161. doi: 10.1093\/cid\/cis462","journal-title":"Clin Infect Dis"},{"key":"2501_CR100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/24.3.324","volume":"24","author":"R Fekety","year":"1997","unstructured":"Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME (1997) Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 24:324\u2013333","journal-title":"Clin Infect Dis"},{"key":"2501_CR101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","volume":"357","author":"L Kyne","year":"2001","unstructured":"Kyne L, Warny M, Qamar A, Kelly CP (2001) Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357:189\u2013193","journal-title":"Lancet"},{"key":"2501_CR102","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.mayocp.2012.07.016","volume":"87","author":"S Khanna","year":"2012","unstructured":"Khanna S, Pardi DS (2012) Clostridium difficile infection: new insights into management. Mayo Clin Proc 87:1106\u20131117. doi: 10.1016\/j.mayocp.2012.07.016","journal-title":"Mayo Clin Proc"},{"key":"2501_CR103","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","volume":"351","author":"JK Shim","year":"1998","unstructured":"Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN (1998) Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633\u2013636","journal-title":"Lancet"},{"key":"2501_CR104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-117-4-297","volume":"117","author":"S Johnson","year":"1992","unstructured":"Johnson S, Homann SR, Bettin KM, Quick JN, Clabots CR, Peterson LR, Gerding DN (1992) Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 117:297\u2013302","journal-title":"Ann Intern Med"},{"key":"2501_CR105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2168.1998.00519.x","volume":"85","author":"K Synnott","year":"1998","unstructured":"Synnott K, Mealy K, Merry C, Kyne L, Keane C, Quill R (1998) Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 85:229\u2013231","journal-title":"Br J Surg"},{"key":"2501_CR106","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-155-12-201112200-00007","volume":"155","author":"DM Drekonja","year":"2011","unstructured":"Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, Wilt TJ (2011) Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 155:839\u2013847. doi: 10.7326\/0003-4819-155-12-201112200-00007","journal-title":"Ann Intern Med"},{"key":"2501_CR107","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11605-008-0569-9","volume":"12","author":"JL Hermsen","year":"2008","unstructured":"Hermsen JL, Dobrescu C, Kudsk KA (2008) Clostridium difficile infection: a surgical disease in evolution. J Gastrointest Surg 12:1512\u20131517. doi: 10.1007\/s11605-008-0569-9","journal-title":"J Gastrointest Surg"},{"key":"2501_CR108","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijsu.2008.11.002","volume":"7","author":"S Chan","year":"2009","unstructured":"Chan S, Kelly M, Helme S, Gossage J, Modarai B, Forshaw M (2009) Outcomes following colectomy for Clostridium difficile colitis. Int J Surg 7:78\u201381. doi: 10.1016\/j.ijsu.2008.11.002","journal-title":"Int J Surg"},{"key":"2501_CR109","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1399-3062.2012.00761.x","volume":"14","author":"C Pant","year":"2012","unstructured":"Pant C, Anderson MP, O\u2019Connor JA, Marshall CM, Deshpande A, Sferra TJ (2012) Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database. Transpl Infect Dis 14:540\u2013547. doi: 10.1111\/j.1399-3062.2012.00761.x","journal-title":"Transpl Infect Dis"},{"key":"2501_CR110","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.3748\/wjg.v20.i33.11736","volume":"20","author":"A Trifan","year":"2014","unstructured":"Trifan A, Stanciu C, Stoica O, Girleanu I, Cojocariu C (2014) Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review. World J Gastroenterol 20:11736\u201311742. doi: 10.3748\/wjg.v20.i33.11736","journal-title":"World J Gastroenterol"},{"key":"2501_CR111","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","volume":"57","author":"AN Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG (2008) Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57:205\u2013210","journal-title":"Gut"},{"key":"2501_CR112","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ibd.21457","volume":"17","author":"AN Ananthakrishnan","year":"2011","unstructured":"Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG (2011) Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 17:976\u2013983. doi: 10.1002\/ibd.21457","journal-title":"Inflamm Bowel Dis"},{"key":"2501_CR113","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-991511","volume":"27","author":"G Szabo","year":"2007","unstructured":"Szabo G, Mandrekar P, Dolganiuc A (2007) Innate immune response and hepatic inflammation. Semin Liver Dis 27:339\u2013350","journal-title":"Semin Liver Dis"},{"key":"2501_CR114","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2036.2012.05076.x","volume":"35","author":"PA Reuken","year":"2012","unstructured":"Reuken PA, Pletz MW, Baier M, Pfister W, Stallmach A, Bruns T (2012) Emergence of spontaneous bacterial peritonitis due to enterococci\u2014risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther 35:1199\u20131208. doi: 10.1111\/j.1365-2036.2012.05076.x","journal-title":"Aliment Pharmacol Ther"},{"key":"2501_CR115","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti V, D\u2019Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK (2010) Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 139:1246\u20131256. doi: 10.1053\/j.gastro.2010.06.019","journal-title":"Gastroenterology"},{"key":"2501_CR116","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1378\/chest.07-0202","volume":"132","author":"C Kenneally","year":"2007","unstructured":"Kenneally C, Rosini JM, Skrupky LP, Doherty JA, Hollands JM, Martinez E, McKinzie WE, Murphy T, Smith JR, Micek ST, Kollef MH (2007) Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 132:418\u2013424","journal-title":"Chest"},{"key":"2501_CR117","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2036.2010.04548.x","volume":"33","author":"JR Goodhand","year":"2011","unstructured":"Goodhand JR, Alazawi W, Rampton DS (2011) Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther 33:428\u2013441. doi: 10.1111\/j.1365-2036.2010.04548.x","journal-title":"Aliment Pharmacol Ther"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2501-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2501-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2501-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:35:18Z","timestamp":1559108118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2501-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":117,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2501"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2501-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}